ACM
KERX
Abrams Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-9,108,867
| Closed | -$31M | – | 22 |
|
|
2018
Q3 | $31M | Sell |
9,108,867
-841,188
| -8% | -$2.86M | 0.82% | 19 |
|
|
2018
Q2 | $37.4M | Buy |
9,950,055
+230,879
| +2% | +$868K | 1.04% | 18 |
|
|
2018
Q1 | $39.8M | Hold |
9,719,176
| – | – | 1.25% | 17 |
|
|
2017
Q4 | $45.2M | Buy |
9,719,176
+4,000,000
| +70% | +$18.6M | 1.52% | 16 |
|
|
2017
Q3 | $40.6M | Hold |
5,719,176
| – | – | 1.58% | 14 |
|
|
2017
Q2 | $41.4M | Hold |
5,719,176
| – | – | 1.64% | 15 |
|
|
2017
Q1 | $35.2M | Hold |
5,719,176
| – | – | 1.35% | 15 |
|
|
2016
Q4 | $33.5M | Hold |
5,719,176
| – | – | 1.23% | 16 |
|
|
2016
Q3 | $30.4M | Hold |
5,719,176
| – | – | 1.51% | 15 |
|
|
2016
Q2 | $37.9M | Hold |
5,719,176
| – | – | 1.98% | 11 |
|
|
2016
Q1 | $26.7M | Buy |
5,719,176
+219,176
| +4% | +$1.02M | 1.26% | 16 |
|
|
2015
Q4 | $27.8M | Buy |
5,500,000
+500,000
| +10% | +$2.53M | 1.52% | 15 |
|
|
2015
Q3 | $17.6M | Buy |
+5,000,000
| New | +$17.6M | 1.26% | 14 |
|